Analytical Data
-
Gene name
KAZALD1
- Application
-
Alternative Names
KAZALD1；Kazal-type serine protease inhibitor domain-containing Protein 1
-
Species
Human
-
Source
E. coli
-
Tag
His tag N-Terminus
-
Purity
Greater than 90% as determined by SDS-PAGE.
-
Uniprot
Q96I82
-
Expression Region
31-304aa
-
AA Sequence
RPSPGPDYLR RGWMRLLAEG EGCAPCRPEE CAAPRGCLAG RVRDACGCCW ECANLEGQLC DLDPSAHFYG HCGEQLECRL DTGGDLSRGE VPEPLCACRS QSPLCGSDGH TYSQICRLQE AARARPDANL TVAHPGPCES GPQIVSHPYD TWNVTGQDVI FGCEVFAYPM ASIEWRKDGL DIQLPGDDPH ISVQFRGGPQ RFEVTGWLQI QAVRPSDEGT YRCLGRNALG QVEAPASLTV LTPDQLNSTG IPQLRSLNLV PEEEAESEEN DDYY
-
Endotoxin
< 1.0 EU per μg protein as determined by the LAL method.
-
Form
Freeze-dried powder
-
Buffer formulation
PBS, pH7.4, containing 0.01% SKL, 1mM DTT, 5% Trehalose and Proclin300.
-
Reconstitution
Reconstitute in ddH2O to a concentration of 0.1-0.5 mg/mL. Do not vortex.
- Customization
-
Stability Test
The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37℃ for 48h, and no obvious degradation and precipitation were observed. The loss rate isless than 8% within the expiration date under appropriate storage condition.
-
Storage & Shelf Life
Samples are stable for up to twelve months from date of receipt at -20℃ to -80℃. Store it under sterile conditions at -20℃ to -80℃. It is recommended that the protein be aliquoted for optimal storage. Avoid repeated freeze-thaw cycles.
-
Shipping
In general, recombinant proteins are supplied as lyophilized powder and shipped at ambient temperature. For bulk packages, the proteins are provided as frozen liquid and shipped with blue ice, unless otherwise requested by the customer.
Quality inspection process
Related Products
Protein Description
KAZALD1, a member of the Kazal-type serine protease inhibitor family, has garnered attention due to its potential role in various biological processes and its implications in disease states. Studies have indicated that KAZALD1 is involved in regulating inflammatory responses, wound healing, and other key physiological functions. Its expression patterns suggest that it plays a significant role in tissue remodeling and repair mechanisms. Recent research has focused on the recombinant expression and purification of KAZALD1 to better understand its structure-function relationships and inhibitory mechanisms against serine proteases. By producing KAZALD1 as a recombinant protein, researchers aim to elucidate its interactions with specific proteases and explore its therapeutic potential in conditions such as cancer, autoimmune diseases, and chronic inflammatory disorders. The recombinant KAZALD1 protein serves as a valuable tool for both in vitro and in vivo studies, paving the way for deeper insights into its biological roles and potential applications in drug development and disease management. The growing interest in KAZALD1 emphasizes the need for continued research into its functional properties and regulatory mechanisms, which may ultimately lead to novel therapeutic strategies targeting serine protease-related pathways.
